Cough syrup deaths expose lax drug regulation in India

Lancet. 2022 Oct 22;400(10361):1395. doi: 10.1016/S0140-6736(22)02026-8.
No abstract available

MeSH terms

  • Antitussive Agents* / adverse effects
  • Cough / drug therapy
  • Drug and Narcotic Control
  • Guaifenesin* / therapeutic use
  • Humans
  • India / epidemiology
  • Nonprescription Drugs

Substances

  • Nonprescription Drugs
  • Guaifenesin
  • Antitussive Agents